These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

501 related articles for article (PubMed ID: 19406620)

  • 41. The neuroendocrine basis of sex differences in epilepsy.
    Reddy DS
    Pharmacol Biochem Behav; 2017 Jan; 152():97-104. PubMed ID: 27424276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain structural and neuroendocrine basis of sex differences in epilepsy.
    Reddy DS
    Handb Clin Neurol; 2020; 175():223-233. PubMed ID: 33008527
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Seizure exacerbation and hormonal cycles in women with epilepsy.
    Kim GH; Lee HW; Park H; Lee SK; Lee SA; Kim YI; Song HK; Shin DJ; Hong SB
    Epilepsy Res; 2010 Aug; 90(3):214-20. PubMed ID: 20542664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Occurrence of menstrual cycle related seizure patterns among epileptic women attending the tertiary neurology clinics of the National Hospital of Sri Lanka.
    Kariyawasam SH; Mannapperuma U; Jayasuriya WJ; Weerathunga J; Munasinghe K
    Epilepsy Res; 2009 Apr; 84(2-3):257-62. PubMed ID: 19261442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acetazolamide in women with catamenial epilepsy.
    Lim LL; Foldvary N; Mascha E; Lee J
    Epilepsia; 2001 Jun; 42(6):746-9. PubMed ID: 11422329
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intermittent levetiracetam treatment in five patients with catamenial epilepsy.
    Liu J; Yu N; Sun H; Liang Y; Xie Y; Chen K
    J Pak Med Assoc; 2015 Jul; 65(7):793-5. PubMed ID: 26160095
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Female sex steroids and epilepsy: Part 2. A practical and human focus on catamenial epilepsy.
    Alshakhouri M; Sharpe C; Bergin P; Sumner RL
    Epilepsia; 2024 Mar; 65(3):569-582. PubMed ID: 37925609
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy.
    Tuveri A; Paoletti AM; Orrù M; Melis GB; Marotto MF; Zedda P; Marrosu F; Sogliano C; Marra C; Biggio G; Concas A
    Epilepsia; 2008 Jul; 49(7):1221-9. PubMed ID: 18325018
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progesterone vs placebo therapy for women with epilepsy: A randomized clinical trial.
    Herzog AG; Fowler KM; Smithson SD; Kalayjian LA; Heck CN; Sperling MR; Liporace JD; Harden CL; Dworetzky BA; Pennell PB; Massaro JM;
    Neurology; 2012 Jun; 78(24):1959-66. PubMed ID: 22649214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ferulic acid inhibits catamenial epilepsy through modulation of female hormones.
    Dhillon HK; Singh T; Goel RK
    Metab Brain Dis; 2022 Dec; 37(8):2827-2838. PubMed ID: 35932441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Progesterone and its derivatives for the treatment of catamenial epilepsy: A systematic review.
    Nucera B; Rinaldi F; Dono F; Lanzone J; Evangelista G; Consoli S; Tappatà M; Narducci F; Troisi S; Trinka E; Brigo F
    Seizure; 2023 Jul; 109():52-59. PubMed ID: 37229848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Catamenial epilepsy].
    Mehmedika-Suljić E; Alajbegović A; Loncarević N; Alajbegović S
    Med Arh; 2007; 61(4):248-9. PubMed ID: 18298002
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reproductive endocrine considerations and hormonal therapy for women with epilepsy.
    Herzog AG
    Epilepsia; 1991; 32 Suppl 6():S27-33. PubMed ID: 1959509
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy.
    Herzog AG; Harden CL; Liporace J; Pennell P; Schomer DL; Sperling M; Fowler K; Nikolov B; Shuman S; Newman M
    Ann Neurol; 2004 Sep; 56(3):431-4. PubMed ID: 15349872
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Catamenial epilepsy: gynecological and hormonal implications. Five case reports.
    Rodriguez Macias KA
    Gynecol Endocrinol; 1996 Apr; 10(2):139-42. PubMed ID: 8701789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients.
    Bauer J; Wildt L; Flügel D; Stefan H
    J Neurol; 1992 May; 239(5):284-6. PubMed ID: 1535100
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Epilepsy and menopause: potential implications for pharmacotherapy.
    Sveinsson O; Tomson T
    Drugs Aging; 2014 Sep; 31(9):671-5. PubMed ID: 25079452
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unbalanced progesterone and estradiol secretion in catamenial epilepsy.
    Bonuccelli U; Melis GB; Paoletti AM; Fioretti P; Murri L; Muratorio A
    Epilepsy Res; 1989; 3(2):100-6. PubMed ID: 2651113
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Treatment Approach to Catamenial Epilepsy.
    Navis A; Harden C
    Curr Treat Options Neurol; 2016 Jul; 18(7):30. PubMed ID: 27188699
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Female sex steroids and epilepsy: Part 1. A review of reciprocal changes in reproductive systems, cycles, and seizures.
    Alshakhouri M; Sharpe C; Bergin P; Sumner RL
    Epilepsia; 2024 Mar; 65(3):556-568. PubMed ID: 38036939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.